Birdwatch Note
2023-03-02 04:51:44 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This claim is inaccurate. Data from safety monitoring and research studies show that the vaccine doesn’t increase the risk of worse pregnancy outcomes. Fact Check: https://healthfeedback.org/claimreview/scientific-evidence-shows-covid-19-vaccination-reduces-risk-pregnancy-complications-isnt-associated-with-safety-issues-pfizers-clinical-trial/
Written by 49E68D0F137FBAADC316EEA761B671D21AE8B4A83C0804FF39800AB057A7583E
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1630657339752587271
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1631155302828736512
- noteId - 1631155302828736512
- participantId - 49E68D0F137FBAADC316EEA761B671D21AE8B4A83C0804FF39800AB057A7583E
- noteAuthorParticipantId -
- createdAtMillis - 1677732704250
- tweetId - 1630657339752587271
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This claim is inaccurate. Data from safety monitoring and research studies show that the vaccine doesn’t increase the risk of worse pregnancy outcomes. Fact Check: https://healthfeedback.org/claimreview/scientific-evidence-shows-covid-19-vaccination-reduces-risk-pregnancy-complications-isnt-associated-with-safety-issues-pfizers-clinical-trial/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-02 04:51:44 UTC (1677732704250) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-07 02:11:29 UTC (1678155089929) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-03-02 07:46:19 -0600 | 024C5A352E19A6B7B1A3F6F7CB9D3155077070F876B20B5ED614275701700C76 | Rating Details |
| 2023-03-01 23:48:45 -0600 | 0E3F6EB4AAF7233033251BACE0F0325D12DBDA5E1D67354D15807134017D9D96 | Rating Details |
| 2023-03-02 15:10:27 -0600 | 1B23C746D302CF2525AFD43AE809FEC3D4E2EC39F3C13C4A7D469F5564C1A5AB | Rating Details |
| 2023-03-02 11:42:33 -0600 | 1E6A4D3430D9F1CC74BE403375B80DF09AFC403C18213CBACC14BB9DB0E1E37B | Rating Details |
| 2023-03-02 12:27:08 -0600 | 2EBF26F60F3A7E9005DA089FC61E341428510E1CA440226B1C2CB0CD463748D6 | Rating Details |
| 2023-03-02 01:03:36 -0600 | 42549E58DD5541539288BF2D9CA5733FEF09F81B260A7713EA916F16F2D39F19 | Rating Details |
| 2023-03-02 00:24:40 -0600 | 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 | Rating Details |
| 2023-03-02 01:18:28 -0600 | 45E3479F98865A989593D044115CC3B29909094244C54011865A3F6C2CB11905 | Rating Details |
| 2023-03-03 21:45:48 -0600 | 4A08A16EDFA31E6D7BD170AEC8253C9D43F3C0037AEE1AD46D0D9429C506C92C | Rating Details |
| 2023-03-01 23:22:32 -0600 | 4BADC1ABC23B2EEC73F15A383455E7296023B6D040260316AB9345C4784388DC | Rating Details |
| 2023-03-03 07:40:08 -0600 | 53898DB17ECDDB8648EEF935CB6A549F98569E6619DAFF240C313863886015F6 | Rating Details |
| 2023-03-02 11:36:37 -0600 | 623F900CD7C9F8C490EF084B063BCAA87DFECDFC5B94A127B70830D86D50EAF5 | Rating Details |
| 2023-03-02 09:40:49 -0600 | 71A8D089BB7143D7CFA04A0D7EEF5C32B3B2901386875FDE172BA7A711F2ADB9 | Rating Details |
| 2023-03-02 13:16:36 -0600 | 7587F5B33DD8E4C45A2E4C461E5F5B0A54079B0BF91FE7259A82DB5054CF0D6C | Rating Details |
| 2023-03-02 12:24:03 -0600 | 79B1CC8EA3B4689D759CE3D4CE937CB1FA0B1D99F41F6EEA3BC708F44031D337 | Rating Details |
| 2023-03-02 00:26:01 -0600 | 8313F78A6CC490974D7682937F6424376F0EB02118263D09A6D06A1C2E665613 | Rating Details |
| 2023-03-03 13:10:38 -0600 | 862E84AD6C488AB3037EAC4682346692F09F61D556BF80E01E4F8B21C28D08CA | Rating Details |
| 2023-03-02 11:50:50 -0600 | 8852CE7112C67A95F7E93E6F2EB6038963CAC26FB4E4B013FDFADD9F82567AF3 | Rating Details |
| 2023-03-02 10:11:13 -0600 | 8CEE4BD5B08A0A54D78289E1CEF353621955B3DF8B50ECF9AE9F9EF435F0C52D | Rating Details |
| 2023-03-02 08:54:19 -0600 | 9055B04F8349422D4A5B5B981AAA5D47EC63850FA8796F59199685D1F5EF050E | Rating Details |
| 2023-03-02 08:49:55 -0600 | 9A4E41E5F4A2E5DFC3CF7FBB28EDB3898B0C69125D54DB69DC2E16FDE2913324 | Rating Details |
| 2023-03-02 13:40:45 -0600 | 9C9A53A2EBCF1E34AD4653D320996FE0273A8FFD5F8DEEEC8BCC6A0E46CE07AF | Rating Details |
| 2023-03-02 07:29:54 -0600 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
| 2023-03-02 00:48:43 -0600 | A9A8607FE4FE0CD18AE13794D9EC217725E661DD19CEFCA65D8B92907822DE32 | Rating Details |
| 2023-03-03 13:01:10 -0600 | AACCC71FD9DEFAD8C08C21220E7DF9B0D17A651880639CC58F24999A3ECE55A8 | Rating Details |
| 2023-03-02 06:18:06 -0600 | AF922BF63E71D1A1EDDBEAD5B9AA0D0D359AAD31C391075C68793C9D923C6B73 | Rating Details |
| 2023-03-02 00:18:41 -0600 | B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A | Rating Details |
| 2023-03-02 06:53:16 -0600 | BFD362D8DB09477A2332048155C2014E4E033224F770E7165D29EE077681F1C5 | Rating Details |
| 2023-03-04 15:28:49 -0600 | C114AE7443E7B8F37927077AEBFF939CF496CCF90C3DC24ACA95F015E2AB6DC7 | Rating Details |
| 2023-03-02 09:56:16 -0600 | C1F013D526C47286AB34C7124EEF321FBDE4FA50839797BCC5433EDCF67FC2F7 | Rating Details |
| 2023-03-02 10:46:56 -0600 | C341A161EF359061A7E5AEC1C4331713CC000C014F79011D41530F4744A86F54 | Rating Details |
| 2023-03-03 13:43:45 -0600 | C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 | Rating Details |
| 2023-03-02 06:49:17 -0600 | C559E982739691E2EFE38F13A971AA3B8B28A962694A86631FB41C5B2274E6C4 | Rating Details |
| 2023-03-02 07:12:16 -0600 | C6A39BAC3A85F80A3D342EBF5069D7BD82CD057A5C332382E2514CBB6EE70E1C | Rating Details |
| 2023-03-02 02:15:47 -0600 | C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B | Rating Details |
| 2023-03-02 05:06:59 -0600 | CB52F3F8AE76F98D5D4E0B13341EF5A8840FFDA1EA8B21B0AC08A25458C8C4EE | Rating Details |
| 2023-03-02 04:43:59 -0600 | E445E5F9485F74A625B40DF75301C63A31026CFC4029ED9450BF6B491C18077A | Rating Details |
| 2023-03-02 03:59:23 -0600 | E47C807189EC41DB4B6EC5D2938FA4B45D7F662AEA14AAA9CC8D228721C0527A | Rating Details |
| 2023-03-02 00:28:07 -0600 | E5D1CFB49703FD1108E2381BCBA76EA8B70E072A002E8420633C2008EC4AED2D | Rating Details |
| 2023-03-02 00:34:25 -0600 | E87EE2844723AF6921C9CB9520F13968D825D7359E96FB395389414B7368A681 | Rating Details |
| 2023-03-02 00:36:37 -0600 | EAB8D4C86B95DA798B19C93AFAF36AB9BE6FCFD9F404E5B121DC358E22276A24 | Rating Details |
| 2023-03-02 02:24:24 -0600 | EC9DFE72C512B5AE83625A0D131E301B9D382C8FD9CD4B9E2BD48997A7B3E104 | Rating Details |
| 2023-03-02 02:18:50 -0600 | FB746B52207C35B814DA947877555D688E684981DA2DC9E5AE01CE20B7DE28EA | Rating Details |
| 2023-03-02 11:42:33 -0600 | Rating Details | |
| 2023-03-02 02:24:24 -0600 | Rating Details | |
| 2023-03-02 02:15:47 -0600 | Rating Details | |
| 2023-03-02 15:10:27 -0600 | Rating Details | |
| 2023-03-02 09:40:49 -0600 | Rating Details | |
| 2023-03-03 07:40:08 -0600 | Rating Details | |
| 2023-03-02 02:18:50 -0600 | Rating Details | |
| 2023-03-02 06:18:06 -0600 | Rating Details | |
| 2023-03-02 06:49:17 -0600 | Rating Details | |
| 2023-03-01 23:22:32 -0600 | Rating Details | |
| 2023-03-04 15:28:49 -0600 | Rating Details | |
| 2023-03-02 00:28:07 -0600 | Rating Details | |
| 2023-03-02 03:59:23 -0600 | Rating Details | |
| 2023-03-02 01:18:28 -0600 | Rating Details | |
| 2023-03-02 13:40:45 -0600 | Rating Details | |
| 2023-03-02 06:53:16 -0600 | Rating Details | |
| 2023-03-02 13:16:36 -0600 | Rating Details | |
| 2023-03-02 07:46:19 -0600 | Rating Details | |
| 2023-03-02 08:54:19 -0600 | Rating Details | |
| 2023-03-02 10:46:56 -0600 | Rating Details | |
| 2023-03-03 13:43:45 -0600 | Rating Details | |
| 2023-03-02 00:24:40 -0600 | Rating Details | |
| 2023-03-02 05:06:59 -0600 | Rating Details | |
| 2023-03-02 09:56:16 -0600 | Rating Details | |
| 2023-03-02 00:48:43 -0600 | Rating Details | |
| 2023-03-02 00:36:37 -0600 | Rating Details | |
| 2023-03-02 12:27:08 -0600 | Rating Details | |
| 2023-03-02 01:03:36 -0600 | Rating Details | |
| 2023-03-02 07:29:54 -0600 | Rating Details | |
| 2023-03-01 23:48:45 -0600 | Rating Details | |
| 2023-03-03 21:45:48 -0600 | Rating Details | |
| 2023-03-03 13:10:38 -0600 | Rating Details | |
| 2023-03-02 00:18:41 -0600 | Rating Details | |
| 2023-03-02 00:34:25 -0600 | Rating Details | |
| 2023-03-02 10:11:13 -0600 | Rating Details | |
| 2023-03-02 12:24:03 -0600 | Rating Details | |
| 2023-03-02 07:12:16 -0600 | Rating Details | |
| 2023-03-02 11:36:37 -0600 | Rating Details | |
| 2023-03-02 00:26:01 -0600 | Rating Details | |
| 2023-03-02 04:43:59 -0600 | Rating Details | |
| 2023-03-02 08:49:55 -0600 | Rating Details | |
| 2023-03-03 13:01:10 -0600 | Rating Details | |
| 2023-03-02 11:50:50 -0600 | Rating Details |